Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
NKTR — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

20.89

Margin Of Safety %

Put/Call OI Ratio

0.32

EPS Next Q Diff

1.27

EPS Last/This Y

0.19

EPS This/Next Y

-2.33

Price

76.47

Target Price

153.22

Analyst Recom

1.18

Performance Q

-8.28

Upside

-243.1%

Beta

-0.76

Ticker: NKTR



20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-07-13NKTR68.360.391.5147410
2026-07-14NKTR67.150.390.3047529
2026-07-15NKTR68.30.360.6546535
2026-07-16NKTR67.220.362.7346597
2026-07-17NKTR68.180.350.0246285
2026-07-20NKTR64.830.273.4132161
2026-07-21NKTR68.40.303.5133193
2026-07-22NKTR69.390.330.4634075
2026-07-23NKTR69.360.340.2134205
2026-07-24NKTR70.70.343.2934289
2026-07-27NKTR71.390.370.0435384
2026-07-28NKTR70.810.360.8935697
2026-07-29NKTR70.680.370.2735727
2026-07-30NKTR71.460.360.2235949
2026-07-31NKTR70.670.360.5636004
2026-08-03NKTR70.50.360.2936154
2026-08-04NKTR72.710.360.1836302
2026-08-05NKTR73.020.360.0236683
2026-08-06NKTR74.050.340.0437938
2026-08-07NKTR76.350.320.0439402
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1



20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-07-13NKTR68.3426.7- -9.54
2026-07-14NKTR67.1526.7- -9.54
2026-07-15NKTR68.2626.7- -9.54
2026-07-16NKTR67.0526.7- -9.54
2026-07-17NKTR68.2126.7- -9.54
2026-07-20NKTR64.9426.7- -9.54
2026-07-21NKTR68.5726.7- -9.54
2026-07-22NKTR69.4126.7- -9.54
2026-07-23NKTR69.4026.7- -9.54
2026-07-24NKTR70.8226.7- -9.54
2026-07-27NKTR71.4026.7- -9.54
2026-07-28NKTR70.7726.7- -9.54
2026-07-29NKTR70.6626.7- -9.54
2026-07-30NKTR71.4726.7- -9.54
2026-07-31NKTR70.6526.7- -9.54
2026-08-03NKTR70.5426.7- -9.54
2026-08-04NKTR70.5426.7- -9.54
2026-08-05NKTR73.0026.7- -9.54
2026-08-06NKTR73.5226.7- -9.54
2026-08-07NKTR76.4726.7- -9.54
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1



20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-07-13NKTR-3.0826.8121.13
2026-07-14NKTR-3.0826.8121.13
2026-07-15NKTR-3.0826.8121.13
2026-07-16NKTR-3.0826.8121.13
2026-07-17NKTR-3.0826.8121.13
2026-07-20NKTR-3.0825.5021.13
2026-07-21NKTR-3.0825.5021.13
2026-07-22NKTR-3.0825.5021.13
2026-07-23NKTR-2.7625.5021.13
2026-07-24NKTR-2.7625.5021.13
2026-07-27NKTR-2.7626.1020.89
2026-07-28NKTR-2.7626.1020.89
2026-07-29NKTR-2.7626.1020.89
2026-07-30NKTR-2.7626.1020.89
2026-07-31NKTR-2.7626.1020.89
2026-08-03NKTR-2.7636.1120.89
2026-08-04NKTR-2.7636.1120.89
2026-08-05NKTR-2.7636.1120.89
2026-08-06NKTR-2.7636.1120.89
2026-08-07NKTR-2.7636.1120.89
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS​

-1.78

Avg. EPS Est. Current Quarter

-2.04

Avg. EPS Est. Next Quarter

-0.52

Insider Transactions

-2.76

Institutional Transactions

36.11

Beta

-0.76

Average Sales Estimate Current Quarter

10

Average Sales Estimate Next Quarter

10

Fair Value

Quality Score

32

Growth Score

23

Sentiment Score

67

Actual DrawDown %

73.7

Max Drawdown 5-Year %

-97.8

Target Price

153.22

P/E

Forward P/E

PEG

P/S

46.44

P/B

2.7

P/Free Cash Flow

EPS

-8.42

Average EPS Est. Cur. Y​

-9.54

EPS Next Y. (Est.)

-11.87

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-284.18

Relative Volume

0.9

Return on Equity vs Sector %

-54.8

Return on Equity vs Industry %

-38.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ NKTR Healthcare
$76.47
📉
Swing / Pullback
Buy the dip on strong trends
53 /100
WEAK
Trend
20/20
Pullback
4/25
Volume
7/15
Valuation
10/20
TP/AR
4/10
Options
8/10
RSI
66.6
Range 1M
97.3%
Sup Dist
5.2%
🚀
Momentum Growth
Ride accelerating trends
N/A
40 /100
WEAK
Momentum
11/25
Growth
12/30
Estimates
2/20
Inst/Vol
7/15
Options
8/10
EPS Yr
8%
EPS NY
-20.3%
52W%
62.8%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +100.4% upside
Quality
6/30
Valuation
16/30
Growth
6/25
Stability
8/10
LT Trend
4/5
Upside
+100.4%
Quality
32
Click a card to see score breakdown Full Analysis →
NKTR — P/E HistoricalBiotechnology
Nektar Therapeutics
Sector: Healthcare
Industry: Biotechnology
Employees: 63
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. It develops rezpegaldesleukin, which is in Phase 2b to treat underlying immune system imbalance in people with autoimmune disorders and inflammatory diseases; NKTR-0165 to treat ulcerative colitis, vitiligo, and multiple sclerosis; NKTR-0166 to treat autoimmune disease; NKTR-422 to treat fibrotic diseases; and NKTR-255 to treat solid tumors and large b-cell lymphoma. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; and Merck KGaA. The company was incorporated in 1990 and is headquartered in San Francisco, California.
NKTR

Latest News

—
Caricamento notizie per NKTR…
stock quote shares NKTR – Nektar Therapeutics Stock Price stock today
news today NKTR – Nektar Therapeutics stock forecast ,stock prediction 2023 2024 2025
marketwatch NKTR – Nektar Therapeutics yahoo finance google finance
stock history NKTR – Nektar Therapeutics invest stock market
stock prices NKTR premarket after hours
ticker NKTR fair value insiders trading